SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech fireworks
An SI Board Since October 2001
Posts SubjectMarks Bans
7424 222 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
5474VVUS +18% at day's high, closed +12% on 2 X ADV The Endocrinologic and Metabtnsaf-7/7/2010
5473It seems reasonable to surmise that Lisa Drakeman was ousted two weeks ago becauDewDiligence_on_SI-7/2/2010
5472Genmab up 50%: LONDON, July 1 (Reuters) - GlaxoSmithkline and Denmark's Gennigel bates-7/2/2010
5471ARNA, Now up 17% to 3.60. Piper Jafray raises target to $10 (from Schwab) Pipemanny t17/1/2010
5470ARNA is up 17% <g> Message 26655587 BernardJibacoa-7/1/2010
5469ARNA up on partnership and pymnts: "Under the terms of the agreement, Arenamlkr-7/1/2010
5468ABII is up 21% after announcement that it will be acquired by CELG on a cash &amJibacoa-6/30/2010
5467JAV up 080 AHs trading above $2.00 now! HOFRA concluding its tender offer it seemlkr-6/29/2010
5466OREX; Holding around $4.50 after yesterday's promising data disclosure: WSJmlkr-6/29/2010
5465Haven't been following this but looks like the market didn't believe it Ian@SI-6/28/2010
5464OREX was up 18% Message 26648795 BernardJibacoa-6/28/2010
5463MIPI: 1.89 today? Molecular Insight Pharmaceuticals (MIPI 1.89, -0.20, -9.57%)mlkr-6/25/2010
5462MIPI is up 61% <g> Message 26639627 BernardJibacoa-6/24/2010
5461AMLN benefiting from ROCHE diabetics drug delay: Amylin, Alkermes gain ground omlkr-6/18/2010
5460Failure of competing drug seen as good for AMLN, now up 15%. Message 26626011 tuck-6/18/2010
5459ONTY was up 23% but is up only 14.76% at present.<g> Message 26622955 BeJibacoa-6/17/2010
5458NBIX was up 18% but is up only 10% at present.<g> Message 26619852 BernaJibacoa-6/16/2010
5457Agreed, but I'll wait til tomorrow to re-enter (if I do).tom pope-6/16/2010
5456Good move Tom, it looks under-done to me at 5.23 (current price increases marketfred hayes-6/16/2010
5455And of course in figuring out based on past history what are the more efficient Biotech Jim-6/16/2010
5454Lupron has been generic for many years, but ABT’s prior experience in marketing DewDiligence_on_SI-6/16/2010
5453I did sell half of mine pre market to escape the traditional swoon biotechs put tom pope-6/16/2010
5452To me this was the expected deal if Egalolix is the real deal. The last trial aBiotech Jim-6/16/2010
5451NBIX - 23% (for the moment) <i> Abbott Laboratories agreed to pay as muchtom pope-6/16/2010
54501 sucker paid 19% more than the 4PM closing price for 100 shares of GNVC when trIan@SI-6/15/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News